Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Lectin‐like oxidized low‐density lipoprotein receptor 1 pathways

Lectin‐like oxidized low‐density lipoprotein receptor 1 pathways Background The role of lectin‐like oxidized low‐density lipoprotein receptor (LOX)‐1 has been implicated in the pathogenesis of different diseases, including atherosclerosis, hypertension, obesity, diabetes mellitus and metabolic syndrome. To date, several studies aimed at partially investigating the mechanistic role of LOX‐1 in these various pathologies. Still, so far, the precise signal transduction pathways involving LOX‐1 have not yet been elucidated. Materials and Methods The most recent data published by the authors as well as others concerning different pathways involving LOX‐1 are collected to formulate the presented updated review. Results One of the most prominent pathways highlighted in the present review is the relationship of LOX‐1 to NADPH oxidase that acts as a major source of harmful free radicals causing oxidative stress in blood vessels. Other pathways involve lipid and glucose metabolism‐mediated signal transduction. Discussion The modulatory role of LOX‐1 on nitric oxide and renin/angiotensin systems as well as on fibrosis, apoptosis and inflammatory pathways is discussed. Conclusion The current review revisits LOX‐1 and its related pathways, implicating LOX‐1 as a target for ameliorating various pathological conditions. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Lectin‐like oxidized low‐density lipoprotein receptor 1 pathways

Loading next page...
 
/lp/wiley/lectin-like-oxidized-low-density-lipoprotein-receptor-1-pathways-Cn4J5pHSgf

References (62)

Publisher
Wiley
Copyright
Copyright © 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
DOI
10.1111/eci.12092
pmid
23594336
Publisher site
See Article on Publisher Site

Abstract

Background The role of lectin‐like oxidized low‐density lipoprotein receptor (LOX)‐1 has been implicated in the pathogenesis of different diseases, including atherosclerosis, hypertension, obesity, diabetes mellitus and metabolic syndrome. To date, several studies aimed at partially investigating the mechanistic role of LOX‐1 in these various pathologies. Still, so far, the precise signal transduction pathways involving LOX‐1 have not yet been elucidated. Materials and Methods The most recent data published by the authors as well as others concerning different pathways involving LOX‐1 are collected to formulate the presented updated review. Results One of the most prominent pathways highlighted in the present review is the relationship of LOX‐1 to NADPH oxidase that acts as a major source of harmful free radicals causing oxidative stress in blood vessels. Other pathways involve lipid and glucose metabolism‐mediated signal transduction. Discussion The modulatory role of LOX‐1 on nitric oxide and renin/angiotensin systems as well as on fibrosis, apoptosis and inflammatory pathways is discussed. Conclusion The current review revisits LOX‐1 and its related pathways, implicating LOX‐1 as a target for ameliorating various pathological conditions.

Journal

European Journal of Clinical InvestigationWiley

Published: Jul 1, 2013

There are no references for this article.